This new op-ed by @richardgold.bsky.social describes how sequencing #OpenScience before #IntellectualProperty companies can accelerate innovation while reducing cost and risk. It features our CACHE Challenges as an example of an open science initiative that can greatly benefit participating SMEs!
Conscience
Simplistic models of #IntellectualProperty get in the way of building a biopharmaceutical company. Here I discuss how going #OpenScience can lead to proprietary rights later on: www.lifescienceleader.com/doc/open-sci... @conscience-network.bsky.social @tridentpct.bsky.social
www.lifescienceleader.com
By sharing early-stage tools and data openly, life sciences companies can minimize duplication and de-risk R&D without risking exclusive rights over valuable assets, writes Richard Gold.
